$0.0004
0[0.00%]
Last update: 12:34PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 2.428K | Mkt Cap7.258K |
| Day Range- - - | 52 Wk Range0.000 - 0.148 |
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC:PARNF), Key Statistics
PARNELL PHARMS HLDGS LTD by Parnell Pharmaceuticals Holdings Ltd. Stock (OTC: PARNF) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
39.5M
Total Assets
47.6M
Total Liabilities
39.5M
Profitability
Net income Growth
- -
Gross Margin
58.92%
Net Margin
-48.4%
EBIT Margin
-27.13%
EBITDA Margin
-27.13%
Operating Margin
-13.2%